# Plain Language Summary: End Price Gouging for Medications Act

This bill aims to prevent pharmaceutical companies from dramatically raising the prices of medications without justification. Specifically, it would prohibit drug manufacturers from increasing the price of an existing medication by more than a certain percentage per year—likely around 10% or tied to inflation, though the exact threshold would be determined during the legislative process. If a company tries to raise prices beyond this limit, they would face financial penalties. The bill essentially says: if you're selling a drug that's already on the market and people depend on it, you can't suddenly jack up the price just because you can.

The law would affect pharmaceutical companies most directly, as they'd face restrictions on how much they can charge for medications year to year. However, the real impact would be felt by patients and families who take medications regularly. People with chronic conditions like diabetes, heart disease, or arthritis often need the same medications for years or decades. Right now, some drug companies raise prices dramatically on these older medications, sometimes by 400% or more, forcing patients to choose between buying medicine and paying for other necessities. This bill would make those price increases much harder to justify and execute.

Insurance companies and government programs like Medicare and Medicaid would also benefit, since they wouldn't have to pay as much for medications, which could help keep insurance premiums and program costs more stable. The bill doesn't prevent all price increases—companies could still raise prices modestly each year—but it stops the kind of extreme price hikes that have made headlines when companies suddenly charge ten times more for a drug that's been around for decades. Essentially, this is about preventing what many people see as unfair profiteering on medications that people need to survive and stay healthy.

End Price Gouging for Medications Act

Merkley, Jeff

End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.